|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Stock issued for services | |||||
| Release of customer allowance liability | |||||
| Loss on extinguishment of debt | |||||
| Provision for credit losses | |||||
| Inventory write-downs | |||||
| Accretion of debt discount | |||||
| Deferred income taxes | |||||
| Impairment of contract fulfillment assets | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Non-trade receivable | |||||
| Related party receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Contract fulfillment assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Deferred tax assets | |||||
| Income tax payable | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock, net of issuance costs | |||||
| Proceeds from promissory notes, net of issuance costs | |||||
| Proceeds (payments) from short-term borrowings | |||||
| Proceeds from stock option exercises, net of taxes paid on vested restricted stock units | |||||
| Proceeds from short-term borrowings | |||||
| Repayment of long-term debt | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Non-cash activities: | |||||
| Purchase of DNA X LLC membership units for redeemable common stock | |||||
| Accrued bonus settled in equity | |||||
| Receivables transferred to satisfy payables | |||||
| Bifurcation of the conversion feature in convertible note | |||||
| Promissory note payments settled with equity | |||||
Loading...